MEK-ERK Pathway Antibodies


The Ras-Raf-MEK-ERK Pathway is a critical cell signaling pathway with numerous implications for cancer biology and therapeutic development. Like the AKT-signaling pathway, this signaling cascade is part of the MAPK pathway that plays a role in the regulation of various cellular processes including proliferation, differentiation, development, learning, cell survival, and, under some conditions, also apoptosis. Many of the mechanisms and known but not completely understood. Faulty regulation or function of multiple components in the pathway are observed in cancer cells. In fact, the activity of the Ras-Raf-MEK-ERK cascade is estimated to be increased in about one-third of all human cancers. Both MEK and ERK are phosphorylated by B-Raf in nearly all melanoma cancers.

MEK-ERK Signaling Pathway


Upon activation from upstream extracellular signaling, Raf activates MEK1 and/or MEK2. The Raf and MEK kinase families have limited substrate specificity, but ERK1 and ERK2 enzymes are promiscuous and catalyze the phosphorylation of dozens of cytoplasmic and nuclear substrates including regulatory molecules and transcription factors. MEK1/MEK2 is activated by Raf through the phosphorylation of two serine sites; S218/S222 and S222/S226 respectively. Activated MEK enzymes then upregulate the ERK proteins. ERK1 and ERK2 are protein-serine/threonine kinases that also participate in the Ras-Raf-MEK-ERK signal transduction cascade. MEK1 and MEK2 kinases catalyze the phosphorylation of human ERK1 and ERK2 at 2 distinct activation residues: ERK Tyr204/187 respectively followed by ERK Thr202/185. The phosphorylation of both tyrosine and threonine is required for enzyme activation. Using fit-for-purpose antibodies to aid in the dissection of the specific roles of the MEK and ERK isoforms will allow for a better understanding of the MEK-ERK pathway and potentially new targets for precision medicine.

Suggested Products for Common Assays

For detection of isoform-specific MEK or ERK, use Rockland’s antibodies that have been raised against MEK1 or MEK2 peptide immunogens, or ERK1 or ERK2 peptide immunogens.

To detect various phosphorylated MEK or ERK isoforms, respective phospho-specific and site-specific antibodies are recommended. For example, MEK phosphorylated at serine S222 or serine 226 position can be detected using phospho-specific MEK pS222 Antibody. Also, detect ERK phosphorylated at Threonine 202 or TyY1360 position.

Recombinant MEK and ERK proteins are available use as controls, and several MEK and ERK protein Products have been made. MEK1 and MEK2 isoforms, including a double mutant activation site knock out mutant. In addition to MEK, the ERK1 and ERK2 isoforms, including an ERK activation double mutant at ERK1 T202A/Y204A or ERK2 T185/187A.

Selected MEK and ERK Antibody Products

Product Application
Anti-MEK1 (MOUSE) Monoclonal   ELISA, WB
Anti-MEK1 (MOUSE) Monoclonal Biotin Conjugated  ELISA, WB
Anti-MEK1 (MOUSE) Monoclonal Peroxidase Conjugated  ELISA, WB
Anti-MEK2 (MOUSE) Monoclonal   ELISA, WB
Anti-MEK2 (MOUSE) Monoclonal Biotin Conjugated  ELISA, WB
Anti-MEK2 (MOUSE) Monoclonal Peroxidase Conjugated  ELISA, WB

MEK and ERK Related Products, Proteins, and Peptide Controls

Product Application
MEK1 N-Term Blocking Peptide  WB
MEK2 N-Term Blocking Peptide WB
MEK1 double mutant human recombinant protein WB
MEK2 double mutant human recombinant protein WB
ERK1 human recombinant protein WB
ERK2 human recombinant protein WB
ERK1 double mutant human recombinant protein  WB
ERK2 double mutant human recombinant protein  WB